Novartis AG
Diamino pyridine derivatives
Last updated:
Abstract:
The present invention describes novel diamino pyridine derivatives exhibiting JAK modulating properties. The present invention also relates to pharmaceutical compositions comprising these novel compounds, methods of using said compounds in the treatment of various diseases and disorders being susceptible to JAK modulation, and processes for preparing the compounds described hereinafter.
Status:
Grant
Type:
Utility
Filling date:
24 Nov 2016
Issue date:
25 Feb 2020